These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3654765)

  • 21. Heterogeneity of transport systems for L-glutamine in mouse mammary gland.
    Sharma R; Kansal VK
    Indian J Biochem Biophys; 2001 Aug; 38(4):241-8. PubMed ID: 11811619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pattern of amino acid exchange across the brain is unaffected by intravenous glutamine supplementation in head trauma patients.
    Berg A; Bellander BM; Wanecek M; Norberg A; Ungerstedt U; Rooyackers O; Wernerman J
    Clin Nutr; 2008 Dec; 27(6):816-21. PubMed ID: 18649974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macromolecular and cell cycle effects of different classes of agents inducing the maturation of human myeloblastic leukemia (ML-1) cells.
    Craig RW; Frankfurt OS; Sakagami H; Takeda K; Bloch A
    Cancer Res; 1984 Jun; 44(6):2421-9. PubMed ID: 6586286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The astroglial ASCT2 amino acid transporter as a mediator of glutamine efflux.
    Bröer A; Brookes N; Ganapathy V; Dimmer KS; Wagner CA; Lang F; Bröer S
    J Neurochem; 1999 Nov; 73(5):2184-94. PubMed ID: 10537079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of a production process in a membrane-aerated stirred tank and up to 1000-L airlift bioreactors using BHK-21 cells and chemically defined protein-free medium.
    Hesse F; Ebel M; Konisch N; Sterlinski R; Kessler W; Wagner R
    Biotechnol Prog; 2003; 19(3):833-43. PubMed ID: 12790647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutamine antagonist with diet deficient in glutamine and aspartate reduce tumor growth.
    Yoshioka K; Takehara H; Okada A; Komi N
    Tokushima J Exp Med; 1992 Jun; 39(1-2):69-76. PubMed ID: 1412455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of 6-diazo-5-oxo-L-norleucine (DON), a glutamine analogue, on cartilaginous differentiation in mouse limb buds in vitro.
    Aydelotte MB; Kochhar DM
    Differentiation; 1975 Oct; 4(2):73-80. PubMed ID: 1183764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutamine and related analogs regulate guanosine monophosphate reductase in Salmonella typhimurium.
    Garber BB; Jochimsen BU; Gots JS
    J Bacteriol; 1980 Jul; 143(1):105-11. PubMed ID: 6249786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Induction of gamma-glutamyltransferase in cultured brain cells].
    Müller WH; Freimüller-Kreutzer B
    Biol Chem Hoppe Seyler; 1985 Apr; 366(4):375-8. PubMed ID: 2862884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Model studies towards prodrugs of the glutamine antagonist 6-diazo-5-oxo-l-norleucine (DON) containing a diazo precursor.
    Gao RD; Hin N; Prchalová E; Pal A; Lam J; Rais R; Slusher BS; Tsukamoto T
    Bioorg Med Chem Lett; 2021 Oct; 50():128321. PubMed ID: 34400301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uptake of glutamine in Xenopus oocytes: inhibition by 6-diazo-5-oxo-L-norleucine and harmaline.
    Hundal HS; Mackenzie B; Taylor PM; Rennie MJ
    Biochem Soc Trans; 1990 Oct; 18(5):944-5. PubMed ID: 2083754
    [No Abstract]   [Full Text] [Related]  

  • 32. Evidence for cycloheximide acting as a glutamine analogue in plant tissue.
    Jones RA
    Biochim Biophys Acta; 1977 Jan; 474(1):154-61. PubMed ID: 401647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of glutamine and glucose analogues in metabolic inhibition of human myeloid leukaemia in vitro.
    Griffiths M; Keast D; Patrick G; Crawford M; Palmer TN
    Int J Biochem; 1993 Dec; 25(12):1749-55. PubMed ID: 8138012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model.
    Shelton LM; Huysentruyt LC; Seyfried TN
    Int J Cancer; 2010 Nov; 127(10):2478-85. PubMed ID: 20473919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulation of DNA synthesis by isoproterenol and its inhibition by actinomycin D.
    Baserga R; Heffler S
    Exp Cell Res; 1967 Jun; 46(3):571-80. PubMed ID: 4951765
    [No Abstract]   [Full Text] [Related]  

  • 36. Sirpiglenastat (DRP-104) Induces Antitumor Efficacy through Direct, Broad Antagonism of Glutamine Metabolism and Stimulation of the Innate and Adaptive Immune Systems.
    Yokoyama Y; Estok TM; Wild R
    Mol Cancer Ther; 2022 Oct; 21(10):1561-1572. PubMed ID: 35930753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of palatal epithelial cell death by altered protein synthesis.
    Pratt RM; Greene RM
    Dev Biol; 1976 Nov; 54(1):135-45. PubMed ID: 1001818
    [No Abstract]   [Full Text] [Related]  

  • 38. Permissive effect of glutamine on the differentiation of fetal mouse small intestine in organ culture.
    Beaulieu JF; Calvert R
    Differentiation; 1985; 29(1):50-5. PubMed ID: 4018460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug.
    Rais R; Lemberg KM; Tenora L; Arwood ML; Pal A; Alt J; Wu Y; Lam J; Aguilar JMH; Zhao L; Peters DE; Tallon C; Pandey R; Thomas AG; Dash RP; Seiwert T; Majer P; Leone RD; Powell JD; Slusher BS
    Sci Adv; 2022 Nov; 8(46):eabq5925. PubMed ID: 36383674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of RNA and protein synthesis in memory formation.
    Rainbow TC
    Neurochem Res; 1979 Jun; 4(3):297-312. PubMed ID: 379675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.